|

Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Vanderbilt University Medical Center1

Indications

  • Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)1
  • Type 1 Diabetes Mellitus1
  • MODY2 Diabetes1
  • Diabetes1
  • Healthy Volunteer1

Nashville, Tennessee1 trial

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Vanderbilt University Medical Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.